Paul R Palmer Limited

Paul R Palmer Limited Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Paul R Palmer Limited, Business consultant, 38a Ferring Lane, Ferring.

In ISO 9001:2015, the quality policy must be maintained as documented information.That sounds straightforward—but poor d...
05/06/2026

In ISO 9001:2015, the quality policy must be maintained as documented information.

That sounds straightforward—but poor document control is one of the most common audit findings organizations face.

Here's what proper quality policy documentation looks like:

A clearly identified, version-controlled document
An approval signature from top management
A defined review cycle with revision history
Controlled distribution so outdated versions aren't in circulation
Accessibility for all relevant personnel and interested parties

One subtle but important point: the standard says the policy should be available to interested parties—not necessarily distributed to everyone. Know the difference.

Good documentation isn't bureaucracy. It's evidence that your commitment is real and your system is in control.

Most audits check whether procedures are followed. The best audits check whether the quality policy is alive.Auditing co...
05/06/2026

Most audits check whether procedures are followed. The best audits check whether the quality policy is alive.

Auditing conformance to the quality policy means asking:

✅Can employees articulate what the quality policy means for their role?
✅Are decisions being made in line with the stated quality commitments?
✅Is top management visibly championing quality—or just endorsing documents?
✅Are quality objectives traceable back to the policy's intent?
✅Has the policy been reviewed in response to organizational changes?

Nonconformance isn't always a broken process. Sometimes it's a policy that was never truly implemented.

The quality policy is the foundation of your QMS. When auditors test that foundation, they're asking the most important question of all:

Do you actually mean what you wrote?

𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗣𝗼𝗹𝗶𝗰𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗖𝗼𝗻𝘁𝗲𝘅𝘁 𝗼𝗳 𝗜𝗦𝗢 𝟵𝟬𝟬𝟭:𝟮𝟬𝟭𝟱ISO 9001:2015 Clause 5.2 is short. But it carries significant weight.Here'...
05/06/2026

𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗣𝗼𝗹𝗶𝗰𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗖𝗼𝗻𝘁𝗲𝘅𝘁 𝗼𝗳 𝗜𝗦𝗢 𝟵𝟬𝟬𝟭:𝟮𝟬𝟭𝟱

ISO 9001:2015 Clause 5.2 is short. But it carries significant weight.

Here's what it actually requires of your quality policy:

✅ Be appropriate to the purpose and context of the organization

✅ Provide a framework for setting quality objectives

✅ Include a commitment to satisfying applicable requirements

✅ Include a commitment to continual improvement

✅ Be available as documented information

✅ Be communicated, understood, and applied within the organization

✅ Be available to relevant interested parties, as appropriate

Eight requirements. Many organizations struggle to meet all of them—not because they're complex, but because they treat the policy as a formality rather than a foundation.

Clause 5.2 isn't a compliance box. It's the anchor of your entire QMS.

Build it that way.

𝗧𝘄𝗼 𝗯𝗶𝗴 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗰𝗼𝗺𝗶𝗻𝗴 𝘂𝗽 𝗮𝗻𝗱 𝗜 𝘁𝗵𝗶𝗻𝗸 𝘆𝗼𝘂'𝗹𝗹 𝘄𝗮𝗻𝘁 𝘁𝗼 𝗯𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗿𝗼𝗼𝗺 𝗳𝗼𝗿 𝗯𝗼𝘁𝗵. 🗓️Next week, we're diving into t...
05/06/2026

𝗧𝘄𝗼 𝗯𝗶𝗴 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗰𝗼𝗺𝗶𝗻𝗴 𝘂𝗽 𝗮𝗻𝗱 𝗜 𝘁𝗵𝗶𝗻𝗸 𝘆𝗼𝘂'𝗹𝗹 𝘄𝗮𝗻𝘁 𝘁𝗼 𝗯𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗿𝗼𝗼𝗺 𝗳𝗼𝗿 𝗯𝗼𝘁𝗵. 🗓️

Next week, we're diving into two questions that I hear constantly from pharma and life sciences professionals:

1️⃣ 𝗜𝘀 𝘆𝗼𝘂𝗿 𝘀𝗸𝗶𝗹𝗹𝘀𝗲𝘁 𝗳𝘂𝘁𝘂𝗿𝗲-𝗽𝗿𝗼𝗼𝗳? The pharma industry is changing faster than most of us expected. AI, digital transformation, shifting regulations — are you keeping up, or quietly falling behind?

2️⃣ 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆. 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹. 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹. 𝗪𝗵𝗶𝗰𝗵 𝗽𝗮𝘁𝗵 𝗶𝘀 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗿𝗶𝗴𝗵𝘁 𝗳𝗼𝗿 𝘆𝗼𝘂? So many talented professionals stay stuck not because of ability — but because they never got a clear map of where they could go.

We're tackling both in free live webinars this coming week.

If you're in pharma and thinking about your next move, these sessions are for you.

Dates and links in the comments 👇

🔬 𝗪𝗵𝗮𝘁 𝗺𝗮𝗸𝗲𝘀 𝗮 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝘁𝗲𝘀𝘁 𝗿𝗲𝘀𝘂𝗹𝘁 𝘁𝗿𝘂𝗹𝘆 𝘁𝗿𝘂𝘀𝘁𝘄𝗼𝗿𝘁𝗵𝘆?👉 The answer lies in Analytical Method Validation (AMV).Befo...
04/06/2026

🔬 𝗪𝗵𝗮𝘁 𝗺𝗮𝗸𝗲𝘀 𝗮 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝘁𝗲𝘀𝘁 𝗿𝗲𝘀𝘂𝗹𝘁 𝘁𝗿𝘂𝗹𝘆 𝘁𝗿𝘂𝘀𝘁𝘄𝗼𝗿𝘁𝗵𝘆?

👉 The answer lies in Analytical Method Validation (AMV).

Before any testing method is used in pharmaceutical quality control, it must be rigorously validated. This process ensures that the method:

✅ Accurately measures what it's supposed to measure

✅ Produces consistent, reproducible results

✅ Performs reliably within defined conditions

AMV isn't just a regulatory checkbox; it's a foundational pillar of patient safety. Whether you're testing drug potency, purity, or stability, a validated method is what stands between a reliable result and a dangerous one.

If you work in pharma, biotech, or regulatory affairs, or you're just getting started in the field, understanding analytical method validation is essential.

Drop a 💬 below if you have questions or insights to share. Always happy to discuss!

💥 𝗛𝗼𝘁 𝘁𝗮𝗸𝗲: 𝗣𝗵𝗮𝗿𝗺𝗮 𝗵𝗮𝘀 𝗮 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝗱𝗱𝗶𝗰𝘁𝗶𝗼𝗻. 💥 We write SOPs for the SOPs.We create deviation reports for the devia...
04/06/2026

💥 𝗛𝗼𝘁 𝘁𝗮𝗸𝗲: 𝗣𝗵𝗮𝗿𝗺𝗮 𝗵𝗮𝘀 𝗮 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝗱𝗱𝗶𝗰𝘁𝗶𝗼𝗻. 💥

We write SOPs for the SOPs.

We create deviation reports for the deviation reports.

And when an FDA inspector walks in, we hand them a 400-page binder and call it "evidence of quality."

It isn't.

Here's what I've learned after years as a QP:

👉 A 10-page procedure nobody follows is worthless.

👉 A 2-page procedure everyone understands is gold.

👉 The volume of your quality system is not proof of its effectiveness.

The best QA teams I've worked with? Their documents are ruthlessly simple. Their people are deeply trained. Their decisions are fast.

The weakest? They hide behind paperwork.

The FDA, MHRA, and EMA aren't impressed by how much you've written. They want to see that you actually understand your own processes.

𝗗𝗼 𝘆𝗼𝘂𝗿 𝗳𝗿𝗼𝗻𝘁𝗹𝗶𝗻𝗲 𝗼𝗽𝗲𝗿𝗮𝘁𝗼𝗿𝘀 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝘆𝗼𝘂𝗿 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝘀𝘆𝘀𝘁𝗲𝗺?

𝗢𝗿 𝗱𝗼 𝘁𝗵𝗲𝘆 𝗷𝘂𝘀𝘁 𝗸𝗻𝗼𝘄 𝘄𝗵𝗲𝗿𝗲 𝘁𝗼 𝗳𝗶𝗻𝗱 𝘁𝗵𝗲 𝗯𝗶𝗻𝗱𝗲𝗿?

Drop your honest answer below. 👇

𝗘𝘃𝗲𝗿 𝘄𝗼𝗻𝗱𝗲𝗿 𝘄𝗵𝗮𝘁 𝗸𝗲𝗲𝗽𝘀 𝗮 𝗱𝗿𝘂𝗴 𝘀𝗮𝗳𝗲 𝗯𝗲𝗳𝗼𝗿𝗲 𝗶𝘁 𝗲𝘃𝗲𝗻 𝗿𝗲𝗮𝗰𝗵𝗲𝘀 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁? 🔍Behind every approved medication lies a stack of c...
03/06/2026

𝗘𝘃𝗲𝗿 𝘄𝗼𝗻𝗱𝗲𝗿 𝘄𝗵𝗮𝘁 𝗸𝗲𝗲𝗽𝘀 𝗮 𝗱𝗿𝘂𝗴 𝘀𝗮𝗳𝗲 𝗯𝗲𝗳𝗼𝗿𝗲 𝗶𝘁 𝗲𝘃𝗲𝗻 𝗿𝗲𝗮𝗰𝗵𝗲𝘀 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁? 🔍

Behind every approved medication lies a stack of critical documents and Drug Master Files (DMFs) are among the most important of them all.

DMFs are confidential submissions made to regulatory agencies (like the FDA) that contain detailed information about:

→ Manufacturing facilities & equipment

→ Processes & production methods

→ Packaging materials & components

→ Excipients & active pharmaceutical ingredients

They're not just paperwork. They're the backbone of trust between manufacturers, drug developers, and regulators.

Here's what makes them powerful:

✅ They protect proprietary information while still enabling regulatory review

✅ They allow manufacturers to share sensitive data with applicants — without losing confidentiality

✅ They streamline the drug approval process by centralising critical technical details

Whether you're a pharmaceutical manufacturer, a drug sponsor, or someone navigating the regulatory landscape, understanding DMFs is non-negotiable.

The more we understand these foundational documents, the better we can build safer, more transparent drug supply chains. 💊

Are you working with DMFs in your regulatory submissions? Drop your thoughts below 👇

A recent conversation with a pharmaceutical leader highlighted a challenge many of us are seeing across the industry:The...
02/06/2026

A recent conversation with a pharmaceutical leader highlighted a challenge many of us are seeing across the industry:

The issue isn't a lack of talent.

The issue is finding professionals who are prepared for the future of pharma.

As our industry continues to evolve through digital transformation, AI, advanced analytics, regulatory complexity, and increasingly patient-centric approaches, the skills required to succeed are changing faster than ever.

Organizations are investing heavily in innovation, but innovation only moves as fast as the people who can implement, manage, and sustain it.

This raises an important question:

📌 Are we doing enough to equip current and future pharmaceutical professionals with the skills needed for tomorrow's challenges?

From Quality and Regulatory Affairs to Manufacturing, Validation, Data Integrity, and AI-enabled decision-making, the expectations placed on professionals continue to expand.

The opportunity is enormous—but so is the responsibility to keep learning.

I'll be discussing this topic in more detail during an upcoming LinkedIn Live session. More details will be shared soon, so be sure to follow for updates.

In the meantime, I'd love to hear your perspective:

👉 Where do you see the biggest skills gap in the pharmaceutical industry today?

The pharma industry is changing faster than most organisations can hire for.New modalities. AI-driven drug discovery. Ev...
02/06/2026

The pharma industry is changing faster than most organisations can hire for.

New modalities. AI-driven drug discovery. Evolving regulatory landscapes. The roles that will define the next decade of pharma… many of them barely exist yet.

So here's the uncomfortable question: 𝗜𝘀 𝘆𝗼𝘂𝗿 𝘁𝗲𝗮𝗺 — 𝗮𝗿𝗲 𝗬𝗢𝗨 — 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗿𝗲𝗮𝗱𝘆 𝗳𝗼𝗿 𝘄𝗵𝗮𝘁'𝘀 𝗰𝗼𝗺𝗶𝗻𝗴?

The skills gap in pharma is real, it's growing, and most people in the industry don't see it until it's already a problem.

Next week, I'll be going live on LinkedIn to dig into exactly this. We'll be talking about what the gap actually looks like, where it hits hardest, and what future-proof talent in pharma really means in 2025 and beyond.

Drop a 💊 in the comments if this is something your organisation is grappling with and stay tuned for the details.

💊 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝘁𝗵𝗲 𝗴𝗲𝗻𝗲𝗿𝗶𝗰 𝗱𝗿𝘂𝗴 𝘆𝗼𝘂 𝘁𝗮𝗸𝗲 𝗺𝗶𝗴𝗵𝘁 𝗻𝗼𝘁 𝗯𝗲𝗵𝗮𝘃𝗲 *𝗲𝘅𝗮𝗰𝘁𝗹𝘆* 𝗹𝗶𝗸𝗲 𝘁𝗵𝗲 𝗯𝗿𝗮𝗻𝗱-𝗻𝗮𝗺𝗲 𝘃𝗲𝗿𝘀𝗶𝗼𝗻, 𝘂𝗻𝗹𝗲𝘀𝘀 𝗶𝘁 𝗽𝗮𝘀𝘀𝗲𝘀 𝗮...
01/06/2026

💊 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝘁𝗵𝗲 𝗴𝗲𝗻𝗲𝗿𝗶𝗰 𝗱𝗿𝘂𝗴 𝘆𝗼𝘂 𝘁𝗮𝗸𝗲 𝗺𝗶𝗴𝗵𝘁 𝗻𝗼𝘁 𝗯𝗲𝗵𝗮𝘃𝗲 *𝗲𝘅𝗮𝗰𝘁𝗹𝘆* 𝗹𝗶𝗸𝗲 𝘁𝗵𝗲 𝗯𝗿𝗮𝗻𝗱-𝗻𝗮𝗺𝗲 𝘃𝗲𝗿𝘀𝗶𝗼𝗻, 𝘂𝗻𝗹𝗲𝘀𝘀 𝗶𝘁 𝗽𝗮𝘀𝘀𝗲𝘀 𝗮 𝘃𝗲𝗿𝘆 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝘁𝗲𝘀𝘁?

That test is called a Bioequivalence Study, and it relies on a core concept: Bioavailability.

🔬 Here's what they mean:

→ Bioavailability refers to how much of a drug actually reaches the bloodstream, and how fast. It's not just about the active ingredient — it's about the rate and extent of absorption.

→ Bioequivalence means two drug formulations (e.g., a generic vs. a brand-name) deliver the same amount of active ingredient to the bloodstream within an acceptable range (typically 80–125%).

Why does this matter?

Generic drugs don't need to replicate the exact formula of the original — they just need to produce the same therapeutic effect. Bioequivalence testing is the scientific bridge that makes this possible.

This is why regulatory bodies like the FDA and EMA can confidently approve generics — not on faith, but on rigorous pharmacokinetic data (think Cmax, Tmax, AUC).

The result? Patients get access to affordable medications that are held to the same efficacy and safety standards as their brand-name counterparts.

📌 Generic ≠ inferior. Generic = bioequivalent.

For anyone working in pharma, regulatory affairs, clinical research, or healthcare — understanding these two concepts is foundational.

What's your experience with bioequivalence in your field? Drop a comment below 👇

Address

38a Ferring Lane
Ferring
BN126QT

Opening Hours

Monday 8am - 5:30pm
Tuesday 8am - 5:30pm
Wednesday 8am - 5:30pm
Thursday 8am - 5:30pm
Friday 8am - 5:30pm

Telephone

+441903366167

Website

Alerts

Be the first to know and let us send you an email when Paul R Palmer Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Paul R Palmer Limited:

Shortcuts

Share

Category